Ernst et al. [36] conducted a randomized, double-blind study in 40 patients to assess whether pentoxifylline 1200 mg/day in combination with exercise increased ACD and ICD compared with placebo plus ...
Cilostazol and isosorbide mononitrate, two widely available drugs that have beneficial effects on endothelial function, appear to improve functional and cognitive outcomes when used in patients who ...
In a large, long-term trial, cilostazol was as effective as aspirin at preventing recurrent stroke and was associated with fewer hemorrhages. Antiplatelet drugs have an established role in secondary ...
The antiplatelet drug cilostazol (which prevents the blood from clotting) works as well as, and might be better than, aspirin in helping to prevent a secondary stroke in Asian patients, but with ...
Triple antiplatelet therapy consisting of cilostazol added to clopidogrel and aspirin does not improve clinical outcomes in patients who receive drug-eluting stents (DES) compared with standard dual ...
SAN DIEGO — Patients with a high–thrombosis-risk paclitaxel-eluting stent who were given cilostazol before undergoing a surgical procedure safely transitioned off dual antiplatelet therapy and had low ...
New results suggest that triple antiplatelet therapy for patients undergoing percutaneous coronary intervention with drug-eluting stents achieves greater platelet inhibition than conventional dual ...
WASHINGTON, DC – OCTOBER 12, 2008 – Results of five research studies and a clinical registry first-report presentation scheduled for the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback